Topical imiquimod therapy is an immune response modifier that may be used to treat some basal cell carcinomas and is applied to the skin as a cream
Together, they create a sustained, optimized growth hormone environment, without the risks of synthetic growth hormone therapy
Conflict of interest HX and SG was employed by company Changzhou Shanmei Pharmaceutical Research and Development Center Co., Ltd.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
10.3748/wjg.v23.i29.5304 4 DuzelA.VlainicJ.AntunovicM.MalekinusicD.VrdoljakB.SamaraM.et al (2017)
10.1016/S1095-6433(03)00089-8 26 HamiltonS
Deletion of the gene encoding ABCA1, responsible for lipidating ApoE in the CNS, resulted in an increase in A deposition (Wahrle et al., 2005) Conversely, overexpression of ABCA1 resulted in a decrease in A deposition (Wahrle et al., 2008) in amyloid mouse models, suggesting that increasing ApoE lipidation can reduce A pathology
